|
Subject: инсульт med. In view of the current practice of dose adjustment, photometric Clauss assays with sample predilution, the batroxobin-based kinetic assay, and the dry-chemistry thrombolytic assessment system (TAS) appear to be the most suitable assays for routine use during *** treatment. Clauss-methods with mechanical endpoint-detection and PT-derived fibrinogen assays are not suitable for dose adjustments.Ребята-коллеги, как сказать? |
| You need to be logged in to post in the forum |